These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8287230)

  • 1. Sporadic amplification of the MYC gene in human osteosarcomas.
    Ladanyi M; Park CK; Lewis R; Jhanwar SC; Healey JH; Huvos AG
    Diagn Mol Pathol; 1993 Sep; 2(3):163-7. PubMed ID: 8287230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
    Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAS is amplified predominantly in surface osteosarcoma.
    Noble-Topham SE; Burrow SR; Eppert K; Kandel RA; Meltzer PS; Bell RS; Andrulis IL
    J Orthop Res; 1996 Sep; 14(5):700-5. PubMed ID: 8893761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of the c-myc proto-oncogene in human chondrosarcoma.
    Castresana JS; Barrios C; Gómez L; Kreicbergs A
    Diagn Mol Pathol; 1992 Dec; 1(4):235-8. PubMed ID: 1342971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPS3 amplification and clinical outcome in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
    Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.
    Onda M; Matsuda S; Higaki S; Iijima T; Fukushima J; Yokokura A; Kojima T; Horiuchi H; Kurokawa T; Yamamoto T
    Cancer; 1996 Jan; 77(1):71-8. PubMed ID: 8630943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma.
    Barrios C; Castresana JS; Ruiz J; Kreicbergs A
    J Orthop Res; 1993 Jul; 11(4):556-63. PubMed ID: 8101872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression through amplification of genes in chromosome region 17p11.2 approximately p12 in high-grade osteosarcoma.
    van Dartel M; Redeker S; Bras J; Kool M; Hulsebos TJ
    Cancer Genet Cytogenet; 2004 Jul; 152(1):8-14. PubMed ID: 15193436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated assessment of potential value of erbB-2 amplification or expression status as novel therapy target in Chinese children and adolescents with osteosarcoma.
    Shang J; Bi ZG; Ji HF; Wang WB
    Chin Med J (Engl); 2009 Jul; 122(13):1521-4. PubMed ID: 19719941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.
    Squire JA; Pei J; Marrano P; Beheshti B; Bayani J; Lim G; Moldovan L; Zielenska M
    Genes Chromosomes Cancer; 2003 Nov; 38(3):215-25. PubMed ID: 14506695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification and rearrangement of c-myc in radiation-induced murine osteosarcomas.
    Sturm SA; Strauss PG; Adolph S; Hameister H; Erfle V
    Cancer Res; 1990 Jul; 50(13):4146-53. PubMed ID: 2141296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2 amplification and overexpression is not present in pediatric osteosarcoma: a tissue microarray study.
    Somers GR; Ho M; Zielenska M; Squire JA; Thorner PS
    Pediatr Dev Pathol; 2005; 8(5):525-32. PubMed ID: 16211448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 gene amplification in metastatic osteosarcoma.
    Ladanyi M; Cha C; Lewis R; Jhanwar SC; Huvos AG; Healey JH
    Cancer Res; 1993 Jan; 53(1):16-8. PubMed ID: 8416741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 gene abnormalities in osteosarcoma.
    Guo W; Wang X; Feng C
    Chin Med J (Engl); 1996 Oct; 109(10):752-5. PubMed ID: 9275350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome.
    Kersting C; Gebert C; Agelopoulos K; Schmidt H; van Diest PJ; Juergens H; Winkelmann W; Kevric M; Gosheger G; Brandt B; Bielack S; Buerger H
    Clin Cancer Res; 2007 May; 13(10):2998-3005. PubMed ID: 17505002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification and overexpression of genes in 17p11.2 ~ p12 in osteosarcoma.
    van Dartel M; Hulsebos TJ
    Cancer Genet Cytogenet; 2004 Aug; 153(1):77-80. PubMed ID: 15325100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic alterations in sarcomas: a histologic correlative study with use of oncogene panels.
    Maillet MW; Robinson RA; Burgart LJ
    Mod Pathol; 1992 Jul; 5(4):410-4. PubMed ID: 1495946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors.
    Araki N; Uchida A; Kimura T; Yoshikawa H; Aoki Y; Ueda T; Takai S; Miki T; Ono K
    Clin Orthop Relat Res; 1991 Sep; (270):271-7. PubMed ID: 1884549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of allelic imbalance at the c-kit gene locus and c-kit overexpression by immunohistochemistry in pediatric osteosarcomas.
    Entz-Werlé N; Marcellin L; Gaub MP; Guerin E; Schneider A; Berard-Marec P; Kalifa C; Brugiere L; Pacquement H; Schmitt C; Tabone MD; Jeanne-Pasquier C; Terrier P; Dijoud F; Oudet P; Lutz P; Babin-Boilletot A
    J Clin Oncol; 2005 Apr; 23(10):2248-55. PubMed ID: 15800315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas.
    Anninga JK; van de Vijver MJ; Cleton-Jansen AM; Kristel PM; Taminiau AH; Nooij M; Egeler RM; Hogendoorn PC
    Eur J Cancer; 2004 May; 40(7):963-70. PubMed ID: 15093570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.